Investor Ab

Institutional investor · Portfolio as of Q3 2024

Q3 2024 biggest moves
  • MDWDMDWD

    MediWound

    New

    0.4% of portfolio

2 changes in all

Top Holdings7 positions

Checking export access…
Activity:
NDAQ

Nasdaq, Inc.

58.2M$4.2B99.6%$32.48+119.17%
20 qtrssince 2019-Q4
Unchanged
0
MDWD

MediWound Ltd.

872,093$15.8M0.4%$18.060.00%
1 qtr
New
50
CHKP

Check Point Software Technologies Ltd.

5,000$964,0500.0%$157.48+22.44%
4 qtrssince 2023-Q4
Unchanged
0
ONTO

Onto Innovation Inc.

3,602$747,6310.0%$181.08-7.96%
3 qtrssince 2024-Q1
Decreased
0
COHR

Coherent Corp.

6,500$577,9150.0%$60.62+46.67%
3 qtrssince 2024-Q1
Unchanged
0
CCL

Carnival Corporation Ltd.

30,000$554,4000.0%———
—
CGNX

Cognex Corporation

5,000$202,5000.0%$40.81-13.45%
4 qtrssince 2023-Q4
Unchanged
0
$4.3B
AUM
7
Positions
Q3 2024
Filing
HI rating · 1.0/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2023-Q2$2,903,938,533-8.78258563974%
2023-Q3$2,831,690,773-2.4879231836%
2023-Q4$3,386,975,38419.6096486345%
2024-Q1$3,676,815,9108.55750317434%
2024-Q2$3,509,042,621-4.56300486907%
2024-Q3$4,266,695,41821.5914390001%
Activity profile
$ moved · Q3'24
New99%Increased0%Decreased1%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.2 years
<1Q14%1-4Q57%1-2Y14%2Y+14%

Investor Ab manages $4.3B across 7 positions as of Q3 2024. Top holdings: NDAQ (99.6%), MDWD (0.4%), CHKP (0.0%). Fund DNA: Concentrated Value. HoldingsIntel Score: 1/5.0.

Top holdings by portfolio weight

Total AUM$4B
NDAQ99.56%
MDWD0.37%
CHKP0.02%
ONTO0.02%
COHR0.01%
CCL0.01%
CGNX0.00%

Portfolio allocation by GICS sector

Sectors4
Financial Services99.56%
Healthcare0.37%
Technology0.06%
Consumer Cyclical0.01%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Financial Services
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L33
Conviction38
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used